Zum Inhalt springen
LURIC

Publikation · PMID 25200615

Fibroblast growth factor 23 (FGF23) and mortality: the Ludwigshafen Risk and Cardiovascular Health Study

Brandenburg VM, Kleber ME, Vervloet MG, Tomaschitz A, Pilz S, Stojakovic T, Delgado G, Grammer TB et al.

C-terminal FGF23 was measured in 2974 LURIC participants and related to mortality over a median 9.9-year follow-up (884 deaths). Age- and sex-adjusted hazard ratios for the highest versus lowest quartile were 2.54 for all-cause and 2.56 for cardiovascular mortality; after full adjustment, each SD increment carried HRs of 1.38 and 1.35, respectively. FGF23 thus independently predicts long-term mortality in this population.

Atherosclerosis, 28. August 2014 | PMID 25200615

Zeitschrift
Atherosclerosis
DOI
10.1016/j.atherosclerosis.2014.08.037
PMID
25200615
Quelle
https://pubmed.ncbi.nlm.nih.gov/25200615/
Zitationen
71 Relative Zitationsrate 2.60 (1,0 = Durchschnitt des Fachgebiets) · NIH iCite, Stand 20.08.2026